Home  >  Product Launches
you can get e-magazine links on WhatsApp.Click here
biopol
Product Launches
+ Font Resize -

Hetero launches generic lapatinib in India

Our Bureau, Mumbai
Friday, January 11, 2019, 16:10 Hrs  [IST]

Hetero, one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs, announces the launch of generic version of lapatinib (250 mg) tablets in India. The product is marketed and distributed under the brand name ‘Hertab’ by Hetero Healthcare Ltd. It is made available in two SKUs, each consisting of 30 tablets and 150 tablets.

Hertab (lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or letrozole, which together, inhibit the growth of cancer cells in patients.

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics.

 

Post Your commentsPOST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
apparao chowdary Jul 8, 2019 7:58 PM
i am interested to get stockist for Andhra Pradesh. Please let me know. Contact 9000 833 933
Kalyan Feb 22, 2019 11:51 AM
Interested to get stockist for Odisha region.
Please let me know. Contact 8939637678
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |